Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Iovance Biotherapeutics, Inc.

Biological Products, (No Diagnostic Substances) · San Carlos, CA, United States

  1. PrincipalsCorleen M. RocheChief Financial OfficerDaniel Gordon KirbyChief Commercial OfficerFinckenstein Friedrich GrafChief Medical Officerand 3 more
  2. CompanyIovance Biotherapeutics, Inc.San Carlos, CA, United States
  3. Phone line+1 (650) 260-7120General business
Request a quote

Iovance Biotherapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker IOVA) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Frederick G VogtInterim CEO & General Counsel

Finance

Corleen M. RocheChief Financial Officer

Operations

Igor BilinskyChief Operating Officer

Sales & commercial

Daniel Gordon KirbyChief Commercial Officer
Everyone else on file (2)
Finckenstein Friedrich GrafChief Medical Officer
Raj K. PuriChief Regulatory Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Corleen M. Roche — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Finckenstein Friedrich Graf — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Frederick G Vogt — Interim CEO & General Counsel

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Daniel Gordon Kirby — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers